Unlike KIAA1549-BRAF fusion transcripts which were near exclusively expressed in grade I astrocytomas, BRAF V600E mutation was detected in 22.6% of grade II-IV tumors but in none of the grade I tumors [36]. This evidence concerns the gene BRAF and astrocytoma (excluding glioblastoma).